Chaturvedi, A. R., Zaveri, H. G., & Patel, D. V. (2026). Topical Tofacitinib for Atopic Dermatitis – Outcomes from Randomized Phase 3 Clinical Trial: First Approval. Indian Journal of Dermatology, 71(1), 44. https://doi.org/10.4103/ijd.ijd_197_24
Chicago Style (17th ed.) CitationChaturvedi, Alok R., Hemant G. Zaveri, and Dhaval V. Patel. "Topical Tofacitinib for Atopic Dermatitis – Outcomes from Randomized Phase 3 Clinical Trial: First Approval." Indian Journal of Dermatology 71, no. 1 (2026): 44. https://doi.org/10.4103/ijd.ijd_197_24.
MLA (9th ed.) CitationChaturvedi, Alok R., et al. "Topical Tofacitinib for Atopic Dermatitis – Outcomes from Randomized Phase 3 Clinical Trial: First Approval." Indian Journal of Dermatology, vol. 71, no. 1, 2026, p. 44, https://doi.org/10.4103/ijd.ijd_197_24.